Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties
Scalded-skin syndrome (L51.200x002) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Toxic epidermal necrolysis (Lyell) (L51.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Stevens-Johnson syndrome (L51.101) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Bullous erythema multiforme (L51.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Nonbullous erythema multiforme (L51.000) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Urticaria is transient pruritic wheals/angioedema; antihistamines, identify/avoid triggers (foods/drugs/infection/physical), systemic steroids if severe, epinephrine for anaphylaxis/angioedema, omalizumab for chronic.
皮肤科Gastrointestinal urticaria (L50.803) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Chronic urticaria is recurrent wheals >6 weeks; antihistamines (up-dosed), omit triggers, identify autoimmune/physical causes, omalizumab, cyclosporine, treat underlying disease.
皮肤科Acute urticaria is transient pruritic wheals <6 weeks; identify/avoid trigger (foods/drugs/infection), antihistamines, systemic steroids if severe, epinephrine for anaphylaxis/angioedema.
皮肤科Acute urticaria (severe) (L50.800x003) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Other urticaria (L50.800) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Contact urticaria is wheals on contact with substance; identify/avoid trigger (food/plants/latex/chemicals), antihistamines, topical steroids, patch/skin-prick testing.
皮肤科Cholinergic urticaria is small wheals on heat/exercise/emotion; antihistamines, avoid triggers, desensitization, omalizumab for refractory.
皮肤科Vibratory urticaria (L50.400) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Dermatographism is whealing on stroking skin; antihistamines, avoid scratching/trauma, reassurance, treat underlying urticaria.
皮肤科Dermatographism (L50.300) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Heat urticaria is wheals on heat exposure; antihistamines, avoid heat/hot showers, cholinergic urticaria variant, monitor anaphylaxis.
皮肤科Cold urticaria is wheals/angioedema on cold exposure; antihistamines, avoid cold exposure, cold-challenge testing, monitor anaphylaxis (swimming), omalizumab for refractory.
皮肤科Cold/heat urticaria (L50.200) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
Idiopathic urticaria (L50.100) is a disease entity listed in the National Clinical Version 2.0 of the Disease Classification and Codes standard issued by the National Health Commission; a detailed pathological introduction is being compiled.
|